BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 14739160)

  • 21. Calcineurin inhibition ameliorates structural, contractile, and electrophysiologic consequences of postinfarction remodeling.
    Deng L; Huang B; Qin D; Ganguly K; El-Sherif N
    J Cardiovasc Electrophysiol; 2001 Sep; 12(9):1055-61. PubMed ID: 11573696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The angiotensin II type 2 receptor and improved adjacent region function post-MI.
    Bove CM; Gilson WD; Scott CD; Epstein FH; Yang Z; Dimaria JM; Berr SS; French BA; Bishop SP; Kramer CM
    J Cardiovasc Magn Reson; 2005; 7(2):459-64. PubMed ID: 15881529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function.
    Hill JA; Rothermel B; Yoo KD; Cabuay B; Demetroulis E; Weiss RM; Kutschke W; Bassel-Duby R; Williams RS
    J Biol Chem; 2002 Mar; 277(12):10251-5. PubMed ID: 11786544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction.
    Ikeuchi M; Matsusaka H; Kang D; Matsushima S; Ide T; Kubota T; Fujiwara T; Hamasaki N; Takeshita A; Sunagawa K; Tsutsui H
    Circulation; 2005 Aug; 112(5):683-90. PubMed ID: 16043643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction in rats.
    Shimada T; Yoshiyama M; Takeuchi K; Omura T; Takemoto Y; Kim S; Iwao H; Yoshikawa J
    Cardiovasc Res; 1998 Mar; 37(3):618-26. PubMed ID: 9659445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential responses of the right ventricle to abnormal loading conditions in mice: pressure vs. volume load.
    Bartelds B; Borgdorff MA; Smit-van Oosten A; Takens J; Boersma B; Nederhoff MG; Elzenga NJ; van Gilst WH; De Windt LJ; Berger RM
    Eur J Heart Fail; 2011 Dec; 13(12):1275-82. PubMed ID: 22024026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Over-expression of calpastatin inhibits calpain activation and attenuates post-infarction myocardial remodeling.
    Ye T; Wang Q; Zhang Y; Song X; Yang D; Li D; Li D; Su L; Yang Y; Ma S
    PLoS One; 2015; 10(3):e0120178. PubMed ID: 25786109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor.
    Bridgman P; Aronovitz MA; Kakkar R; Oliverio MI; Coffman TM; Rand WM; Konstam MA; Mendelsohn ME; Patten RD
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H586-92. PubMed ID: 15764682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-33 induces type-2-cytokine phenotype but exacerbates cardiac remodeling post-myocardial infarction with eosinophil recruitment, worsened systolic dysfunction, and ventricular wall rupture.
    Ghali R; Habeichi NJ; Kaplan A; Tannous C; Abidi E; Bekdash A; Farhat R; Itani H; Jurjus A; Booz GW; Mallat Z; Zouein FA
    Clin Sci (Lond); 2020 Jun; 134(11):1191-1218. PubMed ID: 32432676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.
    Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H
    Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction.
    Xu J; Carretero OA; Lin CX; Cavasin MA; Shesely EG; Yang JJ; Reudelhuber TL; Yang XP
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1900-7. PubMed ID: 17586619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
    Frank D; Kuhn C; van Eickels M; Gehring D; Hanselmann C; Lippl S; Will R; Katus HA; Frey N
    Circulation; 2007 Nov; 116(22):2587-96. PubMed ID: 18025526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodeling.
    Bove CM; Yang Z; Gilson WD; Epstein FH; French BA; Berr SS; Bishop SP; Matsubara H; Carey RM; Kramer CM
    Hypertension; 2004 Mar; 43(3):680-5. PubMed ID: 14732725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Ikeuchi M; Shiomi T; Matsusaka H; Kubota T; Imanaka-Yoshida K; Itoh T; Takeshita A
    Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1229-35. PubMed ID: 12775562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise attenuates inflammation and limits scar thinning after myocardial infarction in mice.
    Puhl SL; Müller A; Wagner M; Devaux Y; Böhm M; Wagner DR; Maack C
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H345-59. PubMed ID: 26001415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
    Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
    Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
    Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
    Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of Obesity and Hypertension on Cardiac Metabolic Remodeling and Survival Following Myocardial Infarction.
    Mouton AJ; Flynn ER; Moak SP; Li X; da Silva AA; Wang Z; do Carmo JM; Hall ME; Hall JE
    J Am Heart Assoc; 2021 Mar; 10(6):e018212. PubMed ID: 33666098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.